This proof-of-concept randomized controlled clinical trial explores the safety, feasibility, and preliminary efficacy of psilocybin-enhanced psychotherapy versus treatment-as-usual among military Veterans being treated for methamphetamine use disorder within a residential treatment facility.
This proof-of-concept clinical trial is the first to explore the safety and feasibility of MDMA-assisted psychotherapy conducted in a group therapy format. Participants will be military Veterans with PTSD.
Sponsor: Steven & Alexandra Cohen Foundation; study drug provided by Multidisciplinary Association for Psychedelic Studies (MAPS)
We conducted a focus group regarding trauma-related mental health experiences among gender diverse individuals in order to inform a more inclusive approach to the development of MDMA-assisted therapy for this marginalized group. Stay tuned for the development of a multisite clinical trial...
This proof-of-concept randomized controlled clinical trial evaluates the safety and effectiveness of MDMA-assisted therapy for adults with social anxiety disorder.
Principal Investigator: Jason Luoma, PhD - Portland Psychotherapy Clinic
OPEN is a nascent practice-based research network, designed to assess the safety and equity of psilocybin services in community-based settings and develop a framework for future studies. The OPEN project aims to collect confidential information from licensed psilocybin facilitators and their clients to assess their experience with legal psilocybin services.